Vincerx Pharma Ownership 2024 | Who Owns Vincerx Pharma Now?
Institutional Ownership
9.78%
Insider Ownership
18.06%
Retail Ownership
72.15%
Institutional Holders
6.00
Vincerx Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 11.63% | 0.60% | 2,488,418 | 2,488,418 | 100.00% | 2,015,619 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.29% | 0.02% | 1,988,000 | 1,988,000 | 100.00% | 1,610,280 | Jun 30, 2024 |
| SAGE RHINO CAPITAL LLC | 7.96% | 0.33% | 1,703,413 | - | - | 1,379,765 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.17% | 0.02% | 891,719 | - | - | 722,292 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.15% | 0.00% | 674,193 | -280,634 | -29.39% | 546,096 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.95% | 0.00% | 631,421 | -69 | -0.01% | 511,451 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.93% | - | 627,442 | -39,553 | -5.93% | 508,228 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 2.23% | 0.00% | 477,954 | 161,312 | 50.94% | 387,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.54% | 0.00% | 328,533 | 256,967 | 359.06% | 266,112 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 230,785 | 48,302 | 26.47% | 186,986 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.61% | 0.00% | 130,122 | 8,722 | 7.18% | 105,399 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.55% | 0.00% | 116,873 | - | - | 94,667 | Jun 30, 2024 |
| STATE STREET CORP | 0.27% | - | 57,016 | - | - | 46,183,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.22% | - | 47,080 | - | - | 38,134 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.16% | - | 34,297 | -28 | -0.08% | 27,781,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.00% | 18,181 | 18,181 | 100.00% | 14,727 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | - | 17,023 | 17,023 | 100.00% | 13,789 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 11,445 | -14,499 | -55.89% | 9,270 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.05% | - | 10,900 | - | - | 8,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.05% | - | 10,270 | -3,500 | -25.42% | 8,319 | Jun 30, 2024 |
Vincerx Pharma's largest institutional shareholder is PROSIGHT MANAGEMENT, LP, holding 11.63% of the company's total share outstanding, currently valued at $2.02M. The top 10 institutional shareholders own together 46.92% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 11.63% | 0.60% | 2,488,418 | 2,488,418 | 100.00% | 2,015,619 | Jun 30, 2024 |
| SAGE RHINO CAPITAL LLC | 7.96% | 0.33% | 1,703,413 | - | - | 1,379,765 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.17% | 0.02% | 891,719 | - | - | 722,292 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.29% | 0.02% | 1,988,000 | 1,988,000 | 100.00% | 1,610,280 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 2.23% | 0.00% | 477,954 | 161,312 | 50.94% | 387,000 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.55% | 0.00% | 116,873 | - | - | 94,667 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.15% | 0.00% | 674,193 | -280,634 | -29.39% | 546,096 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.00% | 18,181 | 18,181 | 100.00% | 14,727 | Jun 30, 2024 |
| BANK & TRUST CO | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 810 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.54% | 0.00% | 328,533 | 256,967 | 359.06% | 266,112 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.61% | 0.00% | 130,122 | 8,722 | 7.18% | 105,399 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 7,901 | 3,360 | 73.99% | 6,400 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.95% | 0.00% | 631,421 | -69 | -0.01% | 511,451 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.05% | 0.00% | 10,000 | - | - | 8,100 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | - | 17,023 | 17,023 | 100.00% | 13,789 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.05% | - | 10,900 | - | - | 8,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 230,785 | 48,302 | 26.47% | 186,986 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.93% | - | 627,442 | -39,553 | -5.93% | 508,228 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.16% | - | 34,297 | -28 | -0.08% | 27,781,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 11,445 | -14,499 | -55.89% | 9,270 | Jun 30, 2024 |
The largest Vincerx Pharma shareholder by % of total assets is PROSIGHT MANAGEMENT, LP. The company owns 2.49M shares of Vincerx Pharma (VINC), representing 0.60% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 11.63% | 0.60% | 2,488,418 | 2,488,418 | 100.00% | 2,015,619 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.29% | 0.02% | 1,988,000 | 1,988,000 | 100.00% | 1,610,280 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.54% | 0.00% | 328,533 | 256,967 | 359.06% | 266,112 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 2.23% | 0.00% | 477,954 | 161,312 | 50.94% | 387,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.08% | - | 230,785 | 48,302 | 26.47% | 186,986 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.00% | 18,181 | 18,181 | 100.00% | 14,727 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | - | 17,023 | 17,023 | 100.00% | 13,789 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.61% | 0.00% | 130,122 | 8,722 | 7.18% | 105,399 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.04% | 0.00% | 7,901 | 3,360 | 73.99% | 6,400 | Jun 30, 2024 |
| BANK & TRUST CO | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 810 | Jun 30, 2024 |
| BLACKROCK INC. | 0.22% | - | 47,080 | - | - | 38,134 | Jun 30, 2024 |
| STATE STREET CORP | 0.27% | - | 57,016 | - | - | 46,183,000 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.05% | - | 10,900 | - | - | 8,000 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.05% | 0.00% | 10,000 | - | - | 8,100 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 0.55% | 0.00% | 116,873 | - | - | 94,667 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.17% | 0.02% | 891,719 | - | - | 722,292 | Jun 30, 2024 |
| SAGE RHINO CAPITAL LLC | 7.96% | 0.33% | 1,703,413 | - | - | 1,379,765 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.16% | - | 34,297 | -28 | -0.08% | 27,781,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.95% | 0.00% | 631,421 | -69 | -0.01% | 511,451 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -160 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vincerx Pharma's largest institutional buyer is PROSIGHT MANAGEMENT, LP. The company purchased 2.49M stocks of VINC, valued at $2.02M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 210 | -701,213 | -99.97% | 170 | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -385,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 3.15% | 0.00% | 674,193 | -280,634 | -29.39% | 546,096 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -102,049 | -100.00% | - | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | - | - | - | -79,588 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.93% | - | 627,442 | -39,553 | -5.93% | 508,228 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -23,645 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 1,750 | -17,877 | -91.08% | 1,418 | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | - | 11,445 | -14,499 | -55.89% | 9,270 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -11,789 | -100.00% | - | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -5,259 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.05% | - | 10,270 | -3,500 | -25.42% | 8,319 | Jun 30, 2024 |
| UBS GROUP AG | - | - | 1 | -2,497 | -99.96% | 1 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 4 | -2,473 | -99.84% | 4 | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -266 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vincerx Pharma's biggest institutional seller is OCTAGON CAPITAL ADVISORS LP. The company sold -1.00M shares of VINC, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROSIGHT MANAGEMENT, LP | 11.63% | 0.60% | 2,488,418 | 2,488,418 | 100.00% | 2,015,619 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.29% | 0.02% | 1,988,000 | 1,988,000 | 100.00% | 1,610,280 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.09% | 0.00% | 18,181 | 18,181 | 100.00% | 14,727 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | - | 17,023 | 17,023 | 100.00% | 13,789 | Jun 30, 2024 |
| BANK & TRUST CO | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 810 | Jun 30, 2024 |
Vincerx Pharma's largest new institutional shareholder by number of shares is PROSIGHT MANAGEMENT, LP, purchased 2.49M shares, valued at $2.02M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | - | - | - | -385,000 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -102,049 | -100.00% | - | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | - | - | - | -79,588 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -23,645 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | - | - | - | -11,789 | -100.00% | - | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -5,259 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -266 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -160 | -100.00% | - | Jun 30, 2024 |
Vincerx Pharma's largest sold out institutional shareholder by shares sold is OCTAGON CAPITAL ADVISORS LP, sold -1.00M shares, valued at -, as of undefined.
Vincerx Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PUTNAM GLOBAL HEALTH CARE FUND | 0.32% | 533,869 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,068 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,632 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.00% | 10,000 | 10,000 | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 22,974 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 390 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 648,632 | -32,185 | -4.73% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 39,707 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 206,224 | - | - | Jan 31, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 20,655 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,462 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 12,407 | 5,558 | 81.15% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 82,017 | -62,031 | -43.06% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,000 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 6,679 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,725 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 713 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 4,833 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,400 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,648 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 156 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 127,880 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 352 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 53,726 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 546 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 86 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 6,089 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,290 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 20,820 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,509 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,674 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 95 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 16 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 2,367 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,215 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 25,071 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 539 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,812 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 11,100 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,513 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 4,653 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,677 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,103 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,209 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 2,196 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 434 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 5,157 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,240 | - | - | Mar 28, 2024 |
Vincerx Pharma's largest mutual fund holder by % of total assets is "PUTNAM GLOBAL HEALTH CARE FUND", owning 533.87K shares, compromising 0.32% of its total assets.
Vincerx Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | -83.78% |
| 31 Mar, 24 | 37 | 19.35% |
| 31 Dec, 23 | 31 | -11.43% |
| 30 Sep, 23 | 35 | 2.94% |
| 30 Jun, 23 | 34 | -2.86% |
| 31 Mar, 23 | 35 | 2.94% |
| 31 Dec, 22 | 34 | -17.07% |
| 30 Sep, 22 | 41 | -6.82% |
| 30 Jun, 22 | 44 | -33.33% |
| 31 Mar, 22 | 66 | 20.00% |
| 31 Dec, 21 | 55 | - |
| 30 Sep, 21 | 55 | - |
| 30 Jun, 21 | 55 | 48.65% |
| 31 Mar, 21 | 37 | 94.74% |
| 31 Dec, 20 | 19 | - |
As of 30 Jun 24, 6 institutions are holding Vincerx Pharma's shares, representing a decrease of -83.78% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,093,771 | -75.24% |
| 31 Mar, 24 | 8,457,623 | -13.67% |
| 31 Dec, 23 | 9,796,408 | -8.47% |
| 30 Sep, 23 | 10,703,397 | -11.33% |
| 30 Jun, 23 | 12,071,205 | -5.84% |
| 31 Mar, 23 | 12,819,603 | 0.44% |
| 31 Dec, 22 | 12,763,782 | -12.13% |
| 30 Sep, 22 | 14,525,915 | 4.17% |
| 30 Jun, 22 | 13,945,009 | -15.06% |
| 31 Mar, 22 | 16,416,681 | 6.66% |
| 31 Dec, 21 | 15,391,091 | -0.29% |
| 30 Sep, 21 | 15,435,630 | 27.39% |
| 30 Jun, 21 | 12,116,423 | 36.73% |
| 31 Mar, 21 | 8,861,488 | 132.97% |
| 31 Dec, 20 | 3,803,775 | - |
Vincerx Pharma (VINC) has 2.09M shares outstanding as of 30 Jun 24, down -75.24% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 9.78% | 0.63% |
| 31 Mar, 24 | 39.51% | 1.88% |
| 31 Dec, 23 | 45.90% | 1.81% |
| 30 Sep, 23 | 50.31% | 1.55% |
| 30 Jun, 23 | 56.97% | 1.56% |
| 31 Mar, 23 | 60.50% | 1.64% |
| 31 Dec, 22 | 60.70% | 1.28% |
| 30 Sep, 22 | 68.90% | 1.56% |
| 30 Jun, 22 | 66.42% | 1.08% |
| 31 Mar, 22 | 78.56% | 0.98% |
| 31 Dec, 21 | 89.61% | 1.18% |
| 30 Sep, 21 | 87.24% | 1.59% |
| 30 Jun, 21 | 74.11% | 1.78% |
| 31 Mar, 21 | 64.52% | 8.41% |
| 31 Dec, 20 | 27.69% | - |
As of 30 Jun 24, Vincerx Pharma is held by 9.78% institutional shareholders, representing a 0.63% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -80.00% |
| 31 Mar, 24 | 20 | 566.67% |
| 31 Dec, 23 | 3 | -72.73% |
| 30 Sep, 23 | 11 | 57.14% |
| 30 Jun, 23 | 7 | -36.36% |
| 31 Mar, 23 | 11 | 10.00% |
| 31 Dec, 22 | 10 | -23.08% |
| 30 Sep, 22 | 13 | -35.00% |
| 30 Jun, 22 | 20 | -39.39% |
| 31 Mar, 22 | 33 | -13.16% |
| 31 Dec, 21 | 38 | 11.76% |
| 30 Sep, 21 | 34 | -26.09% |
| 30 Jun, 21 | 46 | 58.62% |
| 31 Mar, 21 | 29 | 61.11% |
| 31 Dec, 20 | 18 | - |
4 institutional shareholders have increased their position in VINC stock as of 30 Jun 24 compared to 20 in the previous quarter (a -80.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -91.67% |
| 31 Mar, 24 | 12 | 71.43% |
| 31 Dec, 23 | 7 | -41.67% |
| 30 Sep, 23 | 12 | - |
| 30 Jun, 23 | 12 | 100.00% |
| 31 Mar, 23 | 6 | -64.71% |
| 31 Dec, 22 | 17 | 41.67% |
| 30 Sep, 22 | 12 | - |
| 30 Jun, 22 | 12 | -20.00% |
| 31 Mar, 22 | 15 | 150.00% |
| 31 Dec, 21 | 6 | -53.85% |
| 30 Sep, 21 | 13 | 85.71% |
| 30 Jun, 21 | 7 | 40.00% |
| 31 Mar, 21 | 5 | - |
| 31 Dec, 20 | - | - |
1 institutional shareholders have reduced their position in VINC stock as of 30 Jun 24 compared to 12 in the previous quarter (a -91.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 6 | -83.78% | 2,093,771 | -75.24% | 9.78% | 0.63% | 4 | -80.00% | 1 | -91.67% |
| 31 Mar, 24 | 37 | 19.35% | 8,457,623 | -13.67% | 39.51% | 1.88% | 20 | 566.67% | 12 | 71.43% |
| 31 Dec, 23 | 31 | -11.43% | 9,796,408 | -8.47% | 45.90% | 1.81% | 3 | -72.73% | 7 | -41.67% |
| 30 Sep, 23 | 35 | 2.94% | 10,703,397 | -11.33% | 50.31% | 1.55% | 11 | 57.14% | 12 | - |
| 30 Jun, 23 | 34 | -2.86% | 12,071,205 | -5.84% | 56.97% | 1.56% | 7 | -36.36% | 12 | 100.00% |
| 31 Mar, 23 | 35 | 2.94% | 12,819,603 | 0.44% | 60.50% | 1.64% | 11 | 10.00% | 6 | -64.71% |
| 31 Dec, 22 | 34 | -17.07% | 12,763,782 | -12.13% | 60.70% | 1.28% | 10 | -23.08% | 17 | 41.67% |
| 30 Sep, 22 | 41 | -6.82% | 14,525,915 | 4.17% | 68.90% | 1.56% | 13 | -35.00% | 12 | - |
| 30 Jun, 22 | 44 | -33.33% | 13,945,009 | -15.06% | 66.42% | 1.08% | 20 | -39.39% | 12 | -20.00% |
| 31 Mar, 22 | 66 | 20.00% | 16,416,681 | 6.66% | 78.56% | 0.98% | 33 | -13.16% | 15 | 150.00% |
| 31 Dec, 21 | 55 | - | 15,391,091 | -0.29% | 89.61% | 1.18% | 38 | 11.76% | 6 | -53.85% |
| 30 Sep, 21 | 55 | - | 15,435,630 | 27.39% | 87.24% | 1.59% | 34 | -26.09% | 13 | 85.71% |
| 30 Jun, 21 | 55 | 48.65% | 12,116,423 | 36.73% | 74.11% | 1.78% | 46 | 58.62% | 7 | 40.00% |
| 31 Mar, 21 | 37 | 94.74% | 8,861,488 | 132.97% | 64.52% | 8.41% | 29 | 61.11% | 5 | - |
| 31 Dec, 20 | 19 | - | 3,803,775 | - | 27.69% | - | 18 | - | - | - |
Vincerx Pharma Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vincerx Pharma's stock was made by THOMAS TOM C on Aug 14 2024, selling 175,000 shares at $23.75 per share (valued at $4.16M).
Vincerx Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 24 | 22 | 109.09% |
| Q2 2024 | 9 | - | - |
| Q1 2024 | 4 | - | - |
| Q3 2023 | 6 | - | - |
| Q2 2023 | 5 | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | 7 | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 15 | - | - |
| Q1 2022 | 7 | - | - |
| Q4 2021 | 5 | - | - |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 16 | 1 | 1600.00% |
| Q1 2021 | 3 | 2 | 150.00% |
| Q4 2020 | 12 | - | - |
| Q1 2020 | 3 | 5 | 60.00% |
24 total buy trades, and 22 total sell trades (buy/sell ratio of 1.09%) were made by Vincerx Pharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q3 2023 | 6 | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 5 | - | - |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 9 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q1 2020 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Vincerx Pharma's stocks.
Vincerx Pharma Peer Ownership
| Ticker | Company |
|---|---|
| SNTI | Senti Biosciences, Inc. |
| GRCL | Gracell Biotechnologies Inc. |
| SIOX | Sio Gene Therapies Inc. |
| FRTX | Fresh Tracks Therapeutics, Inc. |
| APLT | Applied Therapeutics, Inc. |
| MNPR | Monopar Therapeutics Inc. |
| XOMA | XOMA Corporation |
| BCAB | BioAtla, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| SRZN | Surrozen, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| VCNX | Vaccinex, Inc. |
| LVTX | LAVA Therapeutics N.V. |
| RZLT | Rezolute, Inc. |
| PCSA | Processa Pharmaceuticals, Inc. |
| TARA | Protara Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| STTK | Shattuck Labs, Inc. |
VINC Ownership FAQ
Who Owns Vincerx Pharma?
Vincerx Pharma is owned by institutional shareholders (9.78%), insiders (18.06%), and public (72.15%). The largest institutional shareholder of Vincerx Pharma is PROSIGHT MANAGEMENT, LP (11.63% of total shares) and the top mutual fund owner is PUTNAM GLOBAL HEALTH CARE FUND (0.32% of total shares).
Who are the major institutional shareholders of Vincerx Pharma?
Vincerx Pharma's major institutional shareholders are PROSIGHT MANAGEMENT, LP, ARMISTICE CAPITAL, LLC, SAGE RHINO CAPITAL LLC, ROCK SPRINGS CAPITAL MANAGEMENT LP, and POINT72 ASSET MANAGEMENT, L.P.. The top five shareholders own together 36.20% of the company's share outstanding.
How many Vincerx Pharma shareholders are there?
As of Jun 2024, there are 6 institutional shareholders of Vincerx Pharma.
What percentage of Vincerx Pharma is owned by PROSIGHT MANAGEMENT, LP?
PROSIGHT MANAGEMENT, LP owns 2.49M shares of Vincerx Pharma, representing 11.63% of the company's total shares outstanding, valued at $2.02M (as of Jun 2024).
What percentage of Vincerx Pharma is owned by ARMISTICE CAPITAL, LLC?
As of Jun 2024, ARMISTICE CAPITAL, LLC holds 1.99M shares of Vincerx Pharma (VINC), compromising 9.29% of the company, valued at $1.61M.
What percentage of Vincerx Pharma is owned by SAGE RHINO CAPITAL LLC?
SAGE RHINO CAPITAL LLC is the third largest holder of Vincerx Pharma. The company owns 1.7M of the company's shares outstanding (worth $1.38M).